eHealthMe - FDA and Social Media, Personalized eHealthMe - FDA and Social Media, Personalized

FDA and Social Media, Personalized

Drugs A-Z       Conditions A-Z       Health Tools       Health Community
Home > Health tools > Drug comparison > Voltaren vs Mobic

Voltaren vs Mobic, a side effect and effectiveness comparison for a female patient aged 51

This is personalized comparison of Voltaren vs Mobic for a female aged 51. The study is created by eHealthMe based on reports from FDA and social media.

What are the drugs

Voltaren (latest outcomes from 20,079 users) has active ingredients of diclofenac sodium. It is often used in arthritis.

Mobic (latest outcomes from 12,486 users) has active ingredients of meloxicam. It is often used in arthritis.

On Oct, 26, 2014: 4,116 female patients aged 46 who take the same drugs are studied in Voltaren vs Mobic

Information of patient in study:

GenderAgeReason for the drug
Female46arthritis

Drugs to compare:

DrugIngredientsCompany
Voltaren diclofenac sodiumNovartis
Mobic meloxicamBoehringer Ingelheim

eHealthMe real world results:

For females aged 46 (±5):

Comparison with the specified adverse outcomes:

(outcome and its % of total reports)

Voltaren (Novartis)Mobic (Boehringer Ingelheim)
Swelling Of Feet And Legs

Most common side effects:

(click on each outcome to view in-depth analysis, incl. how people recovered)
Voltaren (Novartis)Mobic (Boehringer Ingelheim)
Pyrexia (fever)Nausea (feeling of having an urge to vomit)
Arthralgia (joint pain)Pain
Nausea (feeling of having an urge to vomit)Dyspnoea (difficult or laboured respiration)
Headache (pain in head)Headache (pain in head)
DiarrhoeaAnxiety
VomitingPyrexia (fever)
Chest PainDizziness
Fatigue (feeling of tiredness)Chest Pain
Malaise (a feeling of general discomfort or uneasiness)Depression
Dyspnoea (difficult or laboured respiration)Arthralgia (joint pain)

Most common side effects experienced by people in long term use:

(click on each outcome to view in-depth analysis, incl. how people recovered)
Voltaren (Novartis)Mobic (Boehringer Ingelheim)
Dyspepsia (indigestion)Chest Pain
Acute Myocardial Infarction (acute heart attack)Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased)Dizziness
Arteriospasm Coronary (spasm of the large- or medium-sized coronary arteries)Deep Vein Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Weight IncreasedStaphylococcal Infection (an infection with staphylococcus bacteria)
Back InjuryDyspnoea (difficult or laboured respiration)
Neuralgia (pain in one or more nerves)Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Tricuspid Valve Incompetence (inefficient heart valve)Pulmonary Embolism (blockage of the main artery of the lung)
Sacroiliitis (an inflammation of the sacroiliac joint)Pain
Intervertebral Disc DisplacementSepsis (a severe blood infection that can lead to organ failure and death)

Drug effectiveness:

not at allsomewhatmoderatehighvery high
Voltaren6.67%35.24%36.19%12.38%9.52%
Mobic12.15%33.15%32.04%18.23%4.42%

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Next: study your drugs OR ask a question from Patients Like You

Drug effectiveness in real world:

Alternative drugs:

Side effects in real world:

On eHealthMe, Voltaren (diclofenac sodium) is often used to treat arthritis. Mobic (meloxicam) is often used to treat arthritis. Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

Recent related drug comparison:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

44 million health professionals and patients have studied on eHealthMe. Recent studies:

- Doxycycline for a 25-year old man who has Acne-like Skin Bumps (7 minutes ago)

- Escitalopram for a 45-year old woman who has Depression (16 minutes ago)

- Zonisamide for a 1-year old girl who has Epilepsy (25 minutes ago)

 

Recent mobile support groups

- Solu-medrol and Als

- Escitalopram

- Escitalopram and Burning Sensation

- Burning Sensation and Depression

- Depression and Headache - Migraine Without Aura

 

Recent user comments

- "I gave myself 2 injections of Humira one on each thig ... " (3 hours ago)

- "Increase blood glucose while taking herceptin treatme ... " (4 hours ago)

- "It has been almost two months that abovementoined sym ... " (7 hours ago)

 

Recent searches

- Fo Ti Tient
- Hypoxis
- Semen Viscosity Decreased
- Weight Loss Diet
- Vein Disorder

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.